3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
93
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Myelodysplastic Syndromes
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Ototoxicity
1
Neurotoxicity Syndromes
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Microbiota
1
Metabolic Diseases
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Immunologic Deficiency Syndromes
1
Immunoglobulin Light-chain Amyloidosis
1
Hormone Refractory Prostate Cancer
1
Fatigue
1
Central Nervous System Neoplasms
1
Breast Cancer Organoids
1
Breast Cancer Metastatic
1
Brain Neoplasms
1
Interventions
Blood Specimen Collection
5
Drug Therapy
3
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Carboplatin
2
Biopsy, Large-Core Needle
2
Biopsy
2
toripalimab
1
tislelizumab
1
taxane
1
sacituzumab govitecan
1
pembrolizumab
1
atezolizumab
1
Zoledronic Acid
1
Urine Specimen Collection
1
Prophylactic Mastectomy
1
Paracentesis
1
Neuropsychological Tests
1
Mifepristone
1
Medicine, Chinese Traditional
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Immunotherapy
1
Immunohistochemistry
1
Gene Expression Profiling
1
Doxorubicin
1
DNA
1
Cyclophosphamide
1
Combined Modality Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Triple Negative Breast Neoplasms
×
Cyclophosphamide
×
Clear all
NCT05916755
2023-06-23
PORTRAIT
Vall d'Hebron Institute of Oncology
Recruiting
100 enrolled